|
| Press Releases |
|
 |
|
| Wednesday, August 14, 2024 |
|
|
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results |
| Sino Biopharmaceutical Limited (?Sino Biopharmaceutical? or the ?Company?, together with its subsidiaries, the ?Group?) (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2024 (the ?Period?). more info >> |
|
| Friday, March 29, 2024 |
|
|
Sino Biopharm (1177.HK) Announces 2023 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2023. more info >> |
|
| Friday, August 25, 2023 |
|
|
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited interim results for the six months ended 30 June 2023 (the "Period"). more info >> |
|
| Friday, March 31, 2023 |
|
|
Sino Biopharm (1177.HK) Announces 2022 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited financial results for the year ended 31 December 2022. more info >> |
|
| Tuesday, August 23, 2022 |
|
|
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited Interim results for the six months ended 30 June 2022 (the "Period"). more info >> |
|
| Thursday, July 22, 2021 |
|
|
Sino Biopharmaceutical Donates Cash and Supplies Valued at RMB10 Million to Support Henan for Flood Relief and Preventing Epidemic |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced the donation of cash and supplies valued at RMB10 million to support Henan for flood relief and preventing epidemic. more info >> |
|
| Monday, May 24, 2021 |
|
|
Sino Biopharmaceutical 2021 First Quarterly Profit attributable to Owners of the Parent Soars 118.5% to RMB1.91 Billion |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited first quarterly results for the three months ended 31 March 2021. more info >> |
|
| Tuesday, March 23, 2021 |
|
|
Sino Biopharmaceutical 2020 Net Profit Grows to RMB2.77 Billion amid Adversity |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, has announced its audited annual results for the year ended 31 December 2020. more info >> |
|
| Monday, December 7, 2020 |
|
|
Sino Biopharm Invests in Sinovac LS, A Leading COVID-19 Vaccine Company in China |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Group"; HKEX: 1177) has announced the investment of US$515 million in Sinovac Life Sciences Co., Ltd. ("Sinovac LS", previously known as Sinovac Research and Development Co., Ltd.), which will be funded by internal resources of the Group and result in a 15.03% equity interest in Sinovac LS. more info >> |
|
| Monday, November 30, 2020 |
|
|
Sino Biopharmaceutical Announces 2020 Third Quarterly Results |
| Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading and innovation-driven pharmaceutical conglomerate in the PRC, more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Seamless Shopping for K-Culture Lovers: Bringko Expands Cross-Border Services with New Free Shipping Promotion 
Nov 9, 2024 07:00 HKT/SGT
|
|
|
MANAMAURI, the High-Quality Energy Drink Brand, Joins EastBridge Global Investments for Major International Expansion
Nov 9, 2024 06:00 HKT/SGT
|
|
|
Military Metals Announces Appointment of Mark Saxon to Its Board of Directors
Nov 8, 2024 23:58 HKT/SGT
|
|
|
ITC's Final Decision Confirms Innoscience's Customers Remain Unaffected by the Innoscience-EPC Patent Row
Nov 8, 2024 20:23 HKT/SGT
|
|
|
The 32nd Hong Kong International Optical Fair attracts some 13,000 buyers
Nov 8, 2024 20:10 HKT/SGT
|
|
|
Dynasty Wins One Silver and One Bronze Medals at 2024 HKIWSC
Nov 8, 2024 19:32 HKT/SGT
|
|
|
Hong Kong Fashion Designers Association Celebrates 40th Anniversary
Nov 8, 2024 17:56 HKT/SGT
|
|
|
Three Ways AI Tools Can Help Drive Efficiencies for Small Businesses
Nov 8, 2024 16:00 HKT/SGT
|
|
|
TRIO Launches 360 Botslab's Smart Home Security Products in Malaysia, Introducing Advanced AI Solutions to Local Consumers
Nov 8, 2024 14:00 HKT/SGT
|
|
|
International Symposium 'Creating the Future' Sparks Discussions on Technology, Society, and Future Civilization
Nov 8, 2024 14:00 HKT/SGT
|
|
|
ArborChat Outperforms the Market by 750 Basis Points Over a Year
Nov 8, 2024 10:49 HKT/SGT
|
|
|
Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024
Nov 8, 2024 10:31 JST
|
|
|
Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
Nov 7, 2024 22:15 HKT/SGT
|
|
|
Representatives from Over 87 Countries to Participate in the International Symposium 'Creating the Future'
Nov 7, 2024 22:00 HKT/SGT
|
|
|
AdSure Invites Advertisers to Access Top-Quality Finance and Insurance Leads - 10% Conversion Guarantee for Top Funnel Live Leads
Nov 7, 2024 22:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
